Drugs / APPA-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07429565 | Apr → Dec 2018 | osteoarthritis | University of Liverpool | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | APPA-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07429565 ↗ |
| Route | Oral | “It is an orally administered synthetic combination of two compounds:” NCT07429565 ↗ |